Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogliptin Effect on Pulmonary Function in Obese T2DM
NCT02798172Completed
- Sponsor
- Shenyang Fourth People's Hospital
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
Randomised trial of alogliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shenyang Fourth People's Hospital. Primary endpoint: Changes in pulmonary function parameters at 26 weeks. Started May 2014; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02798172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798172.